Intrinsic Value of S&P & Nasdaq Contact Us

Alterity Therapeutics Limited ATHE NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • AU • USD

SharesGrow Score
46/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — ATHE

Alterity Therapeutics Limited (ATHE) has a market capitalization of $33.81M and trades at $3.73. The 52-week range is 2.52-7.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -3.3, Earnings Per Share (EPS) of $-1.14, annual revenue of $5.44M.

The stock has a beta of -0.07, operates in the Healthcare sector.

Trading Data
Current Price$3.73
52-Week Range2.52-7
Volume7.44K
Avg Volume (30D)12.7K
Market Cap$33.81M
Beta (1Y)-0.07
Company
IPO Date2003-09-29
Employees10
CEODavid A. Stamler
CountryAU
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS02155X2053
CUSIP02155X106
Income (Latest Year)
Revenue$5.44M
Gross Profit$5.31M
EBITDA$-14.63M
Operating Income$-14.57M
Net Income$-12.15M
EPS$-1.14
EPS Diluted$-1.14
Shares Outstanding$10.66M
Balance Sheet (Latest Year)
Total Assets$46.03M
Current Assets$45.87M
Cash & ST Investments$40.66M
Total Liabilities$3.62M
Total Debt$155.46K
Net Debt$-33M
Total Equity$42.4M
Debt / Equity0.00
Valuation Ratios
P/E Ratio-3.3
P/S Ratio6.22
P/B Ratio0.8
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message